Research & Innovation - Participant Portal


TOPIC : Global Alliance for Chronic Diseases (GACD) prevention and management of mental disorders

Topic identifier: SC1-HCO-07-2017
Publication date: 14 October 2015

Types of action: RIA Research and Innovation action
Opening date:
28 July 2016
Deadline: 11 April 2017 17:00:00

Time Zone : (Brussels time)
  Horizon 2020 H2020 website
Pillar: Societal Challenges
Work Programme Year: H2020-2016-2017
Topic Updates
  • 28 July 2017 11:56

    An overview of the evaluation results of the single stage (flash call info) that closed on 11 April 2017 is now available under the "Topic conditions and documents" section.

  • 13 January 2017 09:39

     Please note that Switzerland is now officially associated to the Horizon SC1 as well. Swiss participants are therefore eligible to receive Horizon 2020 SC1 support. Please see details in the note here.

Topic Description
Specific Challenge:

The Global Alliance for Chronic Diseases[1] (GACD) call will focus on implementation research proposals on child, adolescent and adult age onset mental disorders[2] including, but not limited to, dementia, depression, schizophrenia, bipolar disorders, alcohol- and drug-use disorders, etc., in low- and middle-income countries (LMIC) and/or in vulnerable populations[3] in high income countries (HIC).

Mental health is an integral part of health as underlined in the World Health Organisation (WHO) definition of health as a 'state of complete physical, mental and social well-being and not merely the absence of disease or infirmity'.

Mental disorders represent an ever-increasing burden, to all ages of the population, challenging mental health and health systems. Depression affects 350 million people in all communities across the world and represents the third leading contributor to the global disease burden[4]. Dementia affects 47.5 million people worldwide with 58% of people living with dementia in low- and middle-income countries[5]. Global costs associated with mental disorders were estimated to € 2.2 trillion in 2010 and are expected to rise to € 5.3 trillion by 2030[6].

Mental disorders place a heavy burden on individuals, families, communities and societies. They also increase the risk of co-morbidities and social exclusion. There are obstacles to achieving effective prevention, early identification and management of mental disorders and to ensuring patients' adherence to therapies. Effective management approaches exist but their implementation in LMIC and vulnerable groups in HIC is hampered by socioeconomic and contextual factors: gender; the stigma associated with mental disorders at work, in health care and communities; the role of traditional medicine in dealing with mental health including trauma; and barriers to accessing care. There is a need to strengthen the evidence base for the contextual scalability of interventions of promising or proven effectiveness for the promotion of mental health and the early identification and management of patients, taking into account the needs of different population groups across the life course.


Proposals must focus on mental disorders as defined by the WHO (see above), and must focus on implementation research in LMIC, and/or in vulnerable populations in HIC. Proposals must build on interventions with promising or proven effectiveness (including cost-effectiveness) for the respective population groups under defined contextual circumstances. Gender-responsive interventions should be addressed, wherever relevant.

The aim should be to adapt and upscale the implementation of these intervention(s) in accessible, affordable and equitable ways in order to improve the prevention and management of mental disorders in the community in medical health care, psychosocial, and public health and other settings and fields. Interventions should meet conditions and requirements of the local health and social system context and address any other contextual factors identified as possible barriers. When economic factors prevent access to effective, low-cost appropriate medication and other management and treatment modalities, proactive policy and strategies should be encouraged to ensure the availability of such medication or other management/treatment modality or means should be found to overcome these barriers.

Each proposal should:

  • Focus on implementation research addressing prevention, and/or early identification and/or management strategies derived from existing knowledge about effective interventions.
  • Include a strategy to test the proposed model of intervention and to address the socioeconomic and contextual factors of relevance to the targeted region and community.
  • Lead to better understanding of key barriers and facilitators at local, national and international level that affect the prevention and management of mental disorders.
  • Include health economics assessments as an integral part of the proposed research, including considerations of scalability and equity.
  • Propose a pathway to embed the intervention into policy and practice addressing:
    • A strategy to include policy makers and local authorities (possibly by being part of the consortium), as well as other relevant stakeholders such as community groups, patient groups, formal and informal carers and any other group, where ever relevant from the beginning of the project, which will contribute to the sustainability of the intervention, after the end of project.
    • Relevance of project outcomes/evidence for scaling up the intervention at local, national and international level and then scaled-up appropriateness with respect to the local social, cultural and economic context.
    • Aspects of stigmatisation and potential equity gaps e.g. due to gender or age.

Proposal must address one of or combinations of the following items:

  • Structural interventions or evidence based policies designed to improve mental health outcomes;
  • Early case detection and other secondary or tertiary prevention strategies as well as modalities of treatment, care and access to care which are amenable to scale-up. Prevention, early identification and treatment may include validated pharmacological, psychotherapeutic, psychosocial support and other approaches of relevance to mental disorders such as accessibility to and enhancing compliance with the intervention, also considering cultural context. Wherever relevant, comorbidities and their impacts on prevention and treatment strategies should be taken into account;
  • Ways to empower people with mental health problems as well as professional and informal care-givers like families according to the context are also relevant;
  • Exploring the scale-up of family/community engagement in patient treatment and care, without pre-empting their living.

The Commission considers that proposals requesting a contribution from the EU of between EUR 1 and 3 million would allow this specific challenge to be addressed appropriately. Nonetheless, this does not preclude submission and selection of proposals requesting other amounts.

Expected Impact:

(one of or combinations of)

  • Advance prevention strategies and implementation of mental health interventions, alleviating global burden of mental disorders;
  • Establish the contextual effectiveness of mental health intervention(s), including at health systems level;
  • Improve tailored prevention and treatment; Develop affordable management and treatment modalities for mental disorders and expand access to care;
  • Inform health service providers, policy and decision makers on effective scaling up of mental health interventions at local, national and regional levels, including affordability aspects for users and health providers;
  • Reduce health inequalities and inequities, including due consideration of gender and age issues where relevant, in the prevention, treatment and care of mental disorders at both local and global levels;
  • Maximise the use of existing relevant programmes and platforms (e.g. research, data, and delivery platforms);
  • Contribute to the United Nations' Sustainable Development Goals 3[7], the Global Action Against Dementia and the First World Health Organisation (WHO) Ministerial Conference on Dementia[8], the WHO Mental Health Action Plan 2013-2020[9], and/or the 2015 European Council Conclusions on dementia[10].

The GACD aims to coordinate research on chronic diseases at global level in order to enhance knowledge exchange across individual projects, and to better understand the impact of socio-economic, cultural, geopolitical and policy on research findings, so as to appropriately adapt health interventions to different geographical, economic and cultural settings. Research under GACD involves regular exchange of research findings and information across participating projects by means of cross-project working groups and annual joint meetings. Wherever feasible, projects should harmonise and standardise their data collection and exchange data.

Applicants must budget for annual costs of having two team members participate in one annual face-to-face meeting of the Global Research Network (location to vary annually). Attendance at this meeting is mandatory for 2 team members, with at least one participant from the LMIC team where relevant. Teams are strongly encouraged to include one junior team member in each annual meeting.

Cross-cutting Priorities:

International cooperation


[2]Mental and behavioural disorders (FOO-F99) of WHO's International Statistical Classification of Diseases and Related Health Problems 10th Revision (lCD-l 0):

[3]Applicants must demonstrate that the proposed population under investigation in HIC is considered as vulnerable.

[4]WHO Fact sheet nr 369, 2012

[5]WHO Fact sheet nr 362, 2015

[6]Bloom, D.E., Cafiero, E.T., Jané-Llopis, E., Abrahams-Gessel, S., Bloom, L.R., Fathima, S., Feigl, A.B., Gaziano, T., Mowafi, M., Pandya, A., Prettner, K., Rosenberg, L., Seligman, B., Stein, A.Z., & Weinstein, C. (2011).The Global Economic Burden of Noncommunicable Diseases. Geneva: World Economic Forum.



[9]WHO Mental Health Action Plan 2013-2020, in particular Objective 2, global target 2 or Objective 3, global target 3:;

[10]2015 European Council Conclusions on dementia: 'Living with dementia: improving care policies and practices':

Topic conditions and documents

Please read carefully all provisions below before the preparation of your application.

  1. List of countries and applicable rules for funding: described in part A of the General Annexes of the General Work Programme.
    Note also that a number of non-EU/non-Associated Countries that are not automatically eligible for funding have made specific provisions for making funding available for their participants in some Horizon 2020 topics (to check funding conditions, follow the links to Australia, BrazilCanada, China, Hong Kong & Macau, IndiaJapan, Republic of Korea, Mexico, Russia, Taiwan, USA*).
    *Note that US participants in projects under the Horizon 2020 "Health, Demographic Change and Wellbeing" Societal Challenge are automatically eligible for EU-funding according to the provisions in the relevant work programme

  2. Eligibility and admissibility conditions: described in part B and C of the General Annexes of the General Work Programme.

    Proposal page limits and layout: Please refer to Part B of the standard proposal template.

  3. Evaluation

    3.1  Evaluation criteria and procedure, scoring and threshold: described in part H of the General Annexes of the General Work Programme.

    3.2 Submission and evaluation process: Guide to the submission and evaluation process

  4. Indicative timetable for evaluation and grant agreement:

    Information on the outcome of single-stage evaluation: maximum 5 months from the deadline for submission.
    Signature of grant agreements: maximum 8 months from the deadline for submission.

  5. Provisions, proposal templates and evaluation forms for the type(s) of action(s) under this topic:

    Research and Innovation Action:

    Specific provisions and funding rates
    Standard proposal template
    Standard evaluation form
    H2020 General MGA -Multi-Beneficiary
    Annotated Grant Agreement

    Essential information for clinical studies

  6. Additional provisions:

    Horizon 2020 budget flexibility

    Classified information

  7. Open access must be granted to all scientific publications resulting from Horizon 2020 actions.

    Where relevant, proposals should also provide information on how the participants will manage the research data generated and/or collected during the project, such as details on what types of data the project will generate, whether and how this data will be exploited or made accessible for verification and re-use, and how it will be curated and preserved.

    Open access to research data
    The Open Research Data Pilot has been extended to cover all Horizon 2020 topics for which the submission is opened on 26 July 2016 or later. Projects funded under this topic will therefore by default provide open access to the research data they generate, except if they decide to opt-out under the conditions described in annex L of the Work Programme. Projects can opt-out at any stage, that is both before and after the grant signature.

    Note that the evaluation phase proposals will not be evaluated more favourably because they plan to open or share their data, and will not be penalised for opting out.

    Open research data sharing applies to the data needed to validate the results presented in scientific publications. Additionally, projects can choose to make other data available open access and need to describe their approach in a Data Management Plan.

    - Projects need to create a Data Management Plan (DMP), except if they opt-out of making their research data open access. A first version of the DMP must be provided as an early deliverable within six months of the project and should be updated during the project as appropriate. The Commission already provides guidance documents, including a template for DMPs.

    - Eligibility of costs: costs related to data management and data sharing are eligible for reimbursement during the project duration.

    The legal requirements for projects participating in this pilot are in the article 29.3 of the Model Grant Agreement.

  8. Additional documents:

    H2020 Work Programme 2016-17: Health, demographic change and wellbeing

    H2020 Work Programme 2016-17: Dissemination, Exploitation and Evaluation

    H2020 Work Programme 2016-17: General Annexes

    Legal basis: Horizon 2020 - Regulation of Establishment

    Legal basis: Horizon 2020 Rules for Participation

    Legal basis: Horizon 2020 Specific Programme


Additional documents

  • FAQ en
  • Flash Call Info (call results) en

Submission Service

No submission system is open for this topic.

Get support

H2020 Online Manual your online guide on the procedures from proposal submission to managing your grant.

Participant Portal FAQ – Submission of proposals.

National Contact Points (NCP) - 
contact your NCP for further assistance.

Research Enquiry Service
– ask questions about any aspect of European research in general and the EU Research Framework Programmes in particular.

Enterprise Europe Network
– contact your EEN national contact for advice to businesses with special focus on SMEs. The support includes guidance on the EU research funding.

IT Helpdesk
- contact the Participant Portal IT helpdesk for questions such as forgotten passwords, access rights and roles, technical aspects of submission of proposals, etc.

Contact the EIT for further assistance related to the call, topics and the content of proposals via the Contact Page on the EIT website.

Clean Sky 2 National Contact Points
- Clean Sky 2 JU States Representative Group

Clean Sky 2 Helpdesk:

ECSEL National Contact Points
– consult Annex G of the ECSEL Work Plan

ECSEL Helpdesk:

IMI States Representative Group (SRG)
– contact you SRG member for assistance.

IMI JU IT Helpdesk
– for IMI2 topics contact the SOFIA IT helpdesk for questions such as forgotten passwords, access rights and roles, technical aspects of submission of proposals, etc.

Shift2Rail Call Helpdesk:

– for compliance with ethical issues, see the Participant Portal and Science and Society Portal

European IPR Helpdesk
assists you on intellectual property issues

and CENELEC, the European Standards Organisations, advise you how to tackle standardisation in your project proposal. Contact CEN-CENELEC Research Helpdesk at

The European Charter for Researchers and the Code of Conduct for their recruitment

Partner Search Services
help you find a partner organisation for your proposal

IMI Partner Search Tool
helps you find a partner organisation for your proposal